The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Biora Inc. | COM NEW | 74319F305 | 14,755,179 | 10,929,762 | SH | SOLE | 10,929,762 | 0 | 0 | ||
Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | 46,311,257 | 72,979,000 | PRN | SOLE | 0 | 0 | 72,979,000 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 7,759,854 | 1,792,114 | SH | SOLE | 1,792,114 | 0 | 0 |